Denise P. Carter
Chief Operating Officer, Director · Quoin Pharmaceuticals, Ltd.
- 2024
- Sep 2, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Denise P. Carter files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Dennis Langer - $129K in QNRX purchases and sales in the last 12 months
- Michael Myers - $100K in QNRX purchases and sales in the last 12 months
- Sally Bridget Lawlor - $50K in QNRX purchases and sales in the last 12 months
- Anthony James Culverwell - $30K in QNRX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Denise P. Carter?
Denise P. Carter is a corporate insider, tracked as Chief Operating Officer, Director of Quoin Pharmaceuticals, Ltd. (QNRX). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Denise P. Carter submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Denise P. Carter been buying or selling stock?
Recorded transactions: 5 open-market purchases ($350K) and 0 open-market sales across all tracked filings.
